Jason P Hecht Selected Research

Labetalol (Normodyne)

9/2021	Blood Pressure Control in Acute Stroke: Labetalol or Nicardipine?
2/2019	Safety of high-dose intravenous labetalol in hypertensive crisis.
2/2018	Continuous-Infusion Labetalol vs Nicardipine for Hypertension Management in Stroke Patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jason P Hecht Research Topics

Disease

2	Venous Thromboembolism 05/2022 - 09/2020
2	Traumatic Brain Injuries (Traumatic Brain Injury) 05/2022 - 01/2020
2	Hypotension (Low Blood Pressure) 09/2021 - 02/2019
2	Bradycardia 09/2021 - 02/2019
2	Stroke (Strokes) 09/2021 - 02/2018
2	Wounds and Injuries (Trauma) 09/2020 - 10/2019
1	Tachycardia (Tachyarrhythmias) 09/2021
1	COVID-19 01/2020
1	Hypertensive Crisis 02/2019
1	Hypertension (High Blood Pressure) 02/2018

Drug/Important Bio-Agent (IBA)

3	Labetalol (Normodyne)FDA LinkGeneric 09/2021 - 02/2018
2	Nicardipine (Dagan)FDA LinkGeneric 09/2021 - 02/2018
2	AnticoagulantsIBA 01/2020 - 10/2019
1	Vitamin K FDA Link 10/2019
1	Antihypertensive Agents (Antihypertensives)IBA 02/2018

Therapy/Procedure

2	Chemoprevention 05/2022 - 09/2020
2	Therapeutics 01/2020 - 10/2019